Source Photonics Announces New 100G ZR4 QSFP28 Transceiver for Data Center Interconnects and Routing Applications
7.12.2020 17:31:00 EET | Business Wire | Press release
Source Photonics, a leading vendor of optical connectivity products used in telecommunication systems and data communications networks, today announces the release of its new 100G ZR4 QSFP28 transceiver for 80km high-speed data center interconnects and routing applications. Leveraging the widely deployed 4 x 25G NRZ optics, 100G ZR4 QSFP28 is the latest addition to the company’s dominant 100G product lines among its leading 100/200/400G portfolio of single-mode transceivers for datacenter and routing applications.
Cloud traffic continues to drive data center growth and the industry requires cost-effective and high-bandwidth interoperable solutions. The Source Photonics 100G ZR4 QSFP28 is cost optimized and low power transceiver supporting 100G Ethernet for extended reach up to 80km transmission that provides point to point network connectivity solutions between data centers or central offices without the need to deploy either complicated, power hungry, and expensive coherent solution or legacy CFP/CFP2 interfaces. The 100G ZR4 QSFP28 alleviates the fiber shortage bottlenecks and enables hyperscale cloud operators to scale their network.
The transceiver is in QSFP28 form factor, the smallest for 100G 80km solution. It is fully compliant with the industry standard QSFP28 and related MSA described in the latest SFF-8665/8636 and digital diagnostic functions are available through an I2C interface. It also complies with IEEE 802.3 100GBASE-ZR4 related specifications. In addition, the module supports standard KR4 FEC (Forward Error Correction) baud rates which will help receive side detect and correct bit errors and improve the overall quality of the link. The 100G ZR4 QSFP28 transceiver is capable to operate over up to 80km point-to-point link without the need for optical amplification and dispersion compensation.
Source Photonics will showcase a product demonstration of the 100G ZR4 QSFP28 transceiver for 80km optical transmission in its virtual booth, in addition to live booth activities, and informative video content during the ECOC 2020 Virtual Exhibition on December 7 to 9.
Source Photonics is currently sampling its 100G ZR4 QSFP28 product, in addition to its latest 100G ER4 and 400G ER8 transceivers. Source Photonics is in full production of its other products for data center and routing applications such as 100G LR4/ER4 Lite, 100G DR1/FR1/LR1, and 400G DR4/FR4/LR4/LR8 transceivers.
For more information about Source Photonics and its product offering, please visit www.sourcephotonics.com.
About Source Photonics:
Source Photonics is a leading provider of innovative and reliable optical communications technology that enables communications and connectivity in datacenters, metro, and access networks. We add value to our customers by developing next-generation solutions that enable their growth by meeting the rapidly increasing demands of cloud infrastructure, wireless communications, routing, and fiber-to-the-premises applications worldwide. Source Photonics has key R&D and manufacturing facilities in California, Taiwan, Chengdu, and Jintan, China.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201207005591/en/
Contact information
Media Contact:
Jasmin Basal
Director, Sales and Marketing
Phone: 818-885-4202
Email: jasmin.basa@sourcephotonics.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Syngenta Signs MoU to Be Strategic Partner in India’s First Open-Data Agricultural Ecosystem Annam.AI15.6.2026 10:35:00 EEST | Press release
India’s agriculture sector is a global powerhouse, uniquely characterized by its massive scale, vast arable land, diverse agro-climatic zones and rich biodiversity. These strengths have propelled the country to become one of the world’s leading producers of crops such as rice and wheat. However, farmers in the country face significant challenges – from erratic monsoons, severe droughts and unseasonal rains compounded by El Nino, to pests and diseases that destroy an estimated 30 percent of crops annually. More than 80 percent of India’s estimated 150 million farming households are composed of smallholder farmers who operate on less than two hectares of land. This limits economies of scale, sets obstacles to the wider adoption of advanced technologies and could widen a systemic gap between large commercial agricultural operations and the bulk of its farming population. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202606151544
Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and Chemistry15.6.2026 10:00:00 EEST | Press release
Pelago Bioscience, a specialist drug discovery focused contract research organization (CRO), known for its industry-leading cell-based target engagement assays, is pleased to announce the acquisition of RG Discovery, and thereby adding deep expertise in medicinal chemistry, custom synthesis, and integrated drug discovery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615340933/en/ Michael Dabrowski, Chief Executive Officer of Pelago Bioscience By combining Pelago Bioscience's biology-focused capabilities with RG Discovery's chemistry expertise, the enlarged platform will enable drug discovery teams to accelerate decision-making, streamline workflows, and advance programs more efficiently from hit identification through lead optimization. "Drug discovery increasingly requires seamless integration between chemistry and biology," said Michael Dabrowski, Chief Executive Officer of Pelago Bioscience. "By bringing RG Discovery
LTM Launches BlueVerse™ for iRun to Outcreate Managed Services in the Agentic AI Era15.6.2026 09:10:00 EEST | Press release
LTM, the Business Creativity partner to the world’s largest enterprises, today announced the launch of BlueVerse™ for iRun, an AI-native managed services model designed to transform traditional IT operations into a resilient, intelligent, and outcome-driven operating model. As enterprise environments grow more complex—spanning hybrid cloud, SaaS, and AI-driven ecosystems—traditional managed services models are increasingly constrained by siloed teams, static processes, and effort-led scaling. BlueVerse for iRun addresses this shift by moving beyond headcount-based delivery to a platform-led approach powered by agentic AI, knowledge convergence, and process-as-code. Built on the BlueVerse ecosystem, iRun creates a unified intelligence layer that brings together enterprise data, telemetry, workflows, and operational context—enabling AI to reason across systems, identify root causes, and execute actions within governed guardrails. iRun combines AI agents and human expertise to shift opera
Azafaros to Present at BIO International Convention 202615.6.2026 08:00:00 EEST | Press release
Azafaros, a private company building a portfolio to become a leader in lysosomal storage disorders (LSDs), focused on addressing neurological symptoms, today announced that it will present at the 2026 BIO International Convention taking place in San Diego, USA, from June 22-25. The company’s presentation is scheduled for Monday, June 22 at 4:30 PM in Theater 4. The presentation will highlight Azafaros’ progress in developing nizubaglustat, its lead investigational compound for the treatment of rare lysosomal storage disorders with neurological involvement, including GM1 and GM2 gangliosidoses (GM1/GM2) and Niemann-Pick type C disease (NPC). Nizubaglustat is currently in two Phase 3 registrational studies (NAVIGATE) treating patients with GM1/GM2 and NPC and expects to report topline data from the studies in 2028. “BIO provides an important opportunity to update our progress as we continue advancing nizubaglustat through late-stage clinical development,” said Stefano Portolano, CEO at A
Teledyne FLIR Defense Launches Black Recon™ Autonomous Micro-Drone15.6.2026 07:05:00 EEST | Press release
Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE: TDY), today announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone system that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260614388428/en/ Teledyne FLIR Defense announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. Black Recon allows crews to launch, operate, recover, and recharge up to three UAS without leaving their platform, reducing operator risk. Designed for vehicle integration, Black Recon allows crews to launch, operate, recover, and recharge up to three unmanned aerial systems without leaving their platform, reducing risk and accelerating decision-making. “Black Recon
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom